Encrypgen Breaking News Mainz Biomed Launches Study for Colon Cancer Screening Test, Aiming for Added Sensitivity US Department of Health and Human Services to Lay Off 10K Workers in Restructuring 23andMe Asset Sale Approved by Bankruptcy Court Invivoscribe Acute Myeloid Leukemia Assay Nabs Regulatory Compliance in UK, Switzerland NCI Awards up to $150M Under Genomic Characterization Center Contract
